Skip to content
Catalyst

PapersPMID:19370686

Huperzine A for vascular dementia.

The Cochrane database of systematic reviews2009The record ↗

  1. Finding, very limited evidenceno difference foundMini-Mental State Examination total score

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “No significant beneficial effect of Huperzine A on the improvement of cognitive function measured by MMSE for VaD (WMD 2.40; 95% CI -4.78 to 9.58) was observed.”
    Study
    RCT
    Effect
    2.4 mean difference, 95% CI −4.78 to 9.58
    Population
    patients with vascular dementia; the review's single included trial

Study record

Design
meta-analysis / randomised controlled trial / systematic review, not pooled
Species
human
Population
patients with vascular dementia (VaD)
Participants
14
Comparator
placebo
Duration
not reported
Endpoints measured
2